Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

12:39 ET BiologicTx®, A BioMatrix Specialty Pharmacy, Announces Significant Enhancements To Kidney Paired Donation Software

BiologicTx, a BioMatrix specialty pharmacy, announced today significant enhancements to their Kidney Paired Donation software, MatchGrid....


12:15 ET Abilify/Abilify Maintena (Otsuka/Lundbeck) Drug Overview & Outlook 2017-2018 to 2026

The "Abilify/Abilify Maintena" report has been added to ResearchAndMarkets.com's offering. Abilify (aripiprazole; Otsuka/Lundbeck) is an atypical...


11:07 ET Pfizer lança no Brasil medicamento inovador para câncer de mama

A Pfizer acaba de lançar o medicamento Ibrance (palbociclibe), uma terapia inovadora para o tratamento do câncer de mama metastático do tipo...


11:05 ET Nimble Pharmacy Expands To Los Angeles And Orange County; Consumers In LA/OC Can Now Skip The Pharmacy Line

Nimble Pharmacy, the on-demand free delivery pharmacy, announced today that it is now operating in Los Angeles and Orange County. As consumers...


10:43 ET Berlin Cures anuncia la formación de su comité asesor científico

Los miembros inaugurales incluyen a expertos en cardiología y autoinmunidad El creador de fármacos Berlin Cures ha anunciado hoy la...


10:37 ET PBM Achieves Dramatic Results With Opioid Management Program

BeneCard PBF, a purely transparent pharmacy benefit manager (PBM), has measurably lowered fraud, waste, abuse and client costs related to opioids,...


09:44 ET FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit

The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products containing benzocaine pose a serious risk...


09:15 ET Global Oxidative Stress Assay (Consumables, Instruments, Services) Market for Pharmaceutical Industry 2018-2022: Key Vendors are Abcam, Merck, Promega, QIAGEN & Thermo Fisher Scientific

The "Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022" report has been added to ResearchAndMarkets.com's offering. The...


09:07 ET Berlin Cures annonce la formation d'un Conseil scientifique consultatif

Les premiers membres comprennent d'éminents experts en cardiologie et auto-immunité Le développeur de médicaments Berlin Cures a annoncé...


09:00 ET Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for XIENCE SierraTM, the newest generation...


08:30 ET Nuvasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...


08:30 ET SCYNEXIS to Participate in a Panel at the 2018 BIO International Convention

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections,...


08:00 ET IOTA Pharmaceuticals Announce the Creation of a Glioblastoma Drug Bank to Support and Accelerate New Research Into Brain Cancer Therapy

IOTA Pharmaceuticals Ltd today announced the creation of a new resource, the Glioblastoma (GBM) Drug Bank, to accelerate drug discovery...


08:00 ET HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic Travel

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced results from the JET Study (VP-VEC-162-2102), a 3-night transatlantic travel...


07:34 ET BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

BERG, LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced that the...


07:30 ET Bayer Presents Preliminary Insights from Global Patient Survey at World Federation of Hemophilia 2018 World Congress

Today, Bayer presented preliminary insights from the U.S. segment of the global HemACTIVE patient survey during a satellite symposium at the World...


07:29 ET mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States

mAbxience, a company specialized in the research, development, manufacturing and global commercialization of monoclonal antibody biosimilars, part...


07:00 ET Alkermes to Present Data on Depression and Schizophrenia Portfolios at Upcoming American Society of Clinical Psychopharmacology Annual Meeting

Alkermes plc (Nasdaq: ALKS) today announced that new clinical data will be presented at the American Society of Clinical Psychopharmacology (ASCP)...


07:00 ET Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a general corporate update in conjunction with its 2018...


07:00 ET Three Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in...


06:37 ET Berlin Cures gibt Bildung eines wissenschaftlichen Beirats bekannt

Zu den Gründungsmitgliedern gehören führende Experten in den Bereichen Kardiologie und Autoimmunität Der Medikamentenentwickler Berlin Cures...


06:30 ET ProSciento Appoints Pete Nieto as Vice President of Business Development

ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic...


06:30 ET TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transformational T Cell Therapy Platform

TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, announced today that Peter Hoang, President and CEO, will host a video...


06:00 ET Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study

Abbott (NYSE: ABT) today announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne Transcatheter Mitral...